Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 20,113-20,124 of 23,847
Drug study icon
CompletedNCT00257166

Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolarity type I (Manic or Mixed)

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.

Multiple locations, including Scottsdale
BipolarityDrugA study involving a medication or substance.From 10 Years to 17 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity
Drug study icon
WithdrawnNCT01117220

Safety And Efficacy Of Ziprasidone In Children And Adolescents With Bipolarity type I (Manic Or Mixed) (Protocol A1281196)

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.

Location not clearly listed
BipolarityDrugFrom 10 Years to 17 Years
Countries
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity
Drug study icon
CompletedNCT02547428

Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

This study exists to compare options and see whether the medication Centanafadine offers something meaningfully different. Researchers are trying to understand how people respond to the medication Centanafadine in practice and what may need to be adjusted.

Multiple locations, including Newport Beach
ADHDDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
ADHD
Drug study icon
TerminatedNCT01674010

Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolarity type I

This study exists to understand how the medication ELND005 holds up over time after the earliest research stage. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.

Multiple locations, including Birmingham
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, France, Canada, ...
Sponsor
OPKO Health, Inc.
Condition
Bipolarity
Device study icon
CompletedNCT01841970

Safety and Efficacy Study of HET Bipolar System for Treatment of Stage I and Stage II Hemorrhoids

This study exists to see whether the medication HET can play a useful role in care. Researchers are trying to understand whether the medication HET can better prevent setbacks and support longer-term stability.

In Cleveland
BipolarityDeviceA study involving a tool, app, wearable, test, or medical device.Over 21 Years
Countries
United States
Sponsor
Medtronic - MITG
Condition
Bipolarity
Drug study icon
CompletedNCT01166425

Safety and Efficacy Study of Lithium for Pediatric Mania.

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Washington D.C.
BipolarityDrugFrom 7 Years to 17 Years
Countries
United States
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.